Glycopeptide: Difference between revisions

Revision as of 12:50, 30 August 2025

Red Man Syndrome: Flushing, rash, itching, hypotension during IV infusion; prevent with slow infusion.
Nephrotoxicity: Kidney damage, especially with high doses or concurrent nephrotoxic drugs; monitor renal function.
Ototoxicity: Hearing loss or tinnitus, more common with high levels or prolonged use.
Hematologic Effects: Neutropenia, thrombocytopenia, or anemia; usually reversible.
Hypersensitivity Reactions: Rash, fever, or severe reactions like Stevens-Johnson syndrome.
Gastrointestinal Issues: Nausea, vomiting, diarrhea (more with oral use).
Other: Phlebitis, elevated liver enzymes, or superinfections.

Authors:

@@ Line 1: / Line 1: @@
+==Adverse Effects==
+* '''Red Man Syndrome''': Flushing, rash, itching, hypotension during IV infusion; prevent with slow infusion.
+* '''Nephrotoxicity''': Kidney damage, especially with high doses or concurrent nephrotoxic drugs; monitor renal function.
+* '''Ototoxicity''': Hearing loss or tinnitus, more common with high levels or prolonged use.
+* '''Hematologic Effects''': Neutropenia, thrombocytopenia, or anemia; usually reversible.
+* '''Hypersensitivity Reactions''': Rash, fever, or severe reactions like Stevens-Johnson syndrome.
+* '''Gastrointestinal Issues''': Nausea, vomiting, diarrhea (more with oral use).
+* '''Other''': Phlebitis, elevated liver enzymes, or superinfections.
+==List of Glycopeptides==
 {{#ask:[[Is DrugClass::Glycopeptide]] |format=ul }}
+{{Template:Clinically Utilized Antibiotics}}
 [[Category:Pharmacology]]
 [[Category:ID]]